Literature DB >> 11352870

CYP17 genotype and ovarian cancer: a null case-control study.

M T Goodman1, K McDuffie, C Guo, K Terada, T A Donlon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352870

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  2 in total

1.  CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.

Authors:  Kristjana Einarsdóttir; Tove Rylander-Rudqvist; Keith Humphreys; Susanne Ahlberg; Gudrun Jonasdottir; Elisabete Weiderpass; Kee Seng Chia; Magnus Ingelman-Sundberg; Ingemar Persson; Jianjun Liu; Per Hall; Sara Wedrén
Journal:  Breast Cancer Res       Date:  2005-09-14       Impact factor: 6.466

2.  Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.

Authors:  C L Pearce; A M Near; D J Van Den Berg; S J Ramus; A Gentry-Maharaj; U Menon; S A Gayther; A R Anderson; C K Edlund; A H Wu; X Chen; J Beesley; P M Webb; S K Holt; C Chen; J A Doherty; M A Rossing; A S Whittemore; V McGuire; R A DiCioccio; M T Goodman; G Lurie; M E Carney; L R Wilkens; R B Ness; K B Moysich; R Edwards; E Jennison; S K Kjaer; E Hogdall; C K Hogdall; E L Goode; T A Sellers; R A Vierkant; J M Cunningham; J C Cunningham; J M Schildkraut; A Berchuck; P G Moorman; E S Iversen; D W Cramer; K L Terry; A F Vitonis; L Titus-Ernstoff; H Song; P D P Pharoah; A B Spurdle; H Anton-Culver; A Ziogas; W Brewster; V Galitovskiy; G Chenevix-Trench
Journal:  Br J Cancer       Date:  2009-01-06       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.